Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil. [PDF]
Alzubaidi RT +6 more
europepmc +1 more source
Fractional CO2 laser for the treatment of Peyronie's disease A pilot clinical trial. [PDF]
Chan JYH +4 more
europepmc +1 more source
Correction: Comment on: "Use of thermographic imaging for the evaluation of erectile dysfunction and Peyronie's disease". [PDF]
Bole R.
europepmc +1 more source
Commentary on "Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil". [PDF]
Barone B +3 more
europepmc +1 more source
An overview of the Canadian landscape on the use of restorative therapies for erectile dysfunction and Peyronie's disease. [PDF]
Shah J +9 more
europepmc +1 more source
High-frequency Ultrasound in Peyronie's Disease: A Case Series. [PDF]
Wattamwar GK +3 more
europepmc +1 more source
Acute Phase Peyronie's Disease: Where Do We Stand? [PDF]
Douroumis K +6 more
europepmc +1 more source
Risk of relationship separation in men with Peyronie's disease in a matched Swedish cohort. [PDF]
Henningsohn L +3 more
europepmc +1 more source
Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases. [PDF]
Paulis G, De Giorgio G, Paulis A.
europepmc +1 more source
Editorial comment on "Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil". [PDF]
Gelbard MK.
europepmc +1 more source

